Literature DB >> 8432225

Patients' attitudes toward screening for gestational diabetes mellitus in the Illawarra area, Australia.

R D Griffiths1, D V Rodgers, R G Moses.   

Abstract

OBJECTIVE: To examine the attitudes toward screening of a group of women who have had GDM compared with a group who were screened but did not have GDM. RESEARCH DESIGN AND METHODS: We surveyed 90 women with GDM and 100 control women with a postal questionnaire. They were asked to mark on a six-point Likert scale their responses to statements about certain aspects of screening for diabetes in pregnancy.
RESULTS: No significant differences were found in mean responses between the two groups. The method of screening was found to be convenient (GDM group, 5.02; control group, 4.77). A strong belief that all women should be screened in pregnancy (GDM group, 5.76; control group, 5.66) and a personal desire for screening in any future pregnancy (GDM group, 5.73; control group, 5.62) were expressed.
CONCLUSIONS: Both groups of women surveyed in this study were extremely positive about the convenience of the screening method used, the need for all women to be screened in pregnancy, and their desire for screening in future pregnancies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432225     DOI: 10.2337/diacare.16.2.506

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  2 in total

1.  German gynecologists' experience with a universal screening for gestational diabetes mellitus in daily practice: A qualitative study.

Authors:  Katharina Diehl; Sven Schneider; Christina Bock; Holger Maul; Helmut Kleinwechter; Tatiana Görig
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-01-12

2.  Classification of hyperglycemia in pregnancy.

Authors:  Veeraswamy Seshiah; Sanjay Kalra; Sanjay Gupte; Hema Divakar; A Murugananthan; Samar Banerjee; Sunil Gupta; Vijayam Balaji; Ah Zargar; Ak Das; Rakesh Sahay; Jitendra Singh; Shaukat Sadikot; Rajesh Khadgawat
Journal:  Indian J Endocrinol Metab       Date:  2014-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.